The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Muscle Relaxers Market Research Report 2024
Synopsis
Muscle relaxers (also called muscle relaxants) are prescription medications that affect muscle function. Healthcare providers prescribe them to treat several symptoms, such as muscle spasms, spasticity and musculoskeletal pain.The term “muscle relaxant” refers to two major drug classes: antispastics and antispasmodics. These two classes differ in their uses, ways of working and side effects.
Global Muscle Relaxers market is projected to reach US$ 5754.8 million in 2029, increasing from US$ 3900 million in 2022, with the CAGR of 5.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Muscle Relaxers market research.
According to a study of Global Burden of Disease (GBD) 2021 data, 1.71 billion individuals globally suffer from musculoskeletal diseases, such as osteoarthritis, rheumatoid arthritis, neck discomfort, low back pain, fractures, and other injuries. People of all ages are afflicted by musculoskeletal problems; however, the prevalence varies by age and diagnosis. With over 149 million years lived with disability (YLDs), or 17% of all YLDs worldwide, musculoskeletal diseases are the main cause of YLDs. The need for muscle relaxants drugs is also being driven by the growing geriatric population, as this group is more vulnerable to illnesses including back pain, muscular tightness, and muscle spasms, especially those connected to injuries to the spine. As a result of this disease muscle relaxants are more in demand, which further drives market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Muscle Relaxers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Novartis
Viatris
Teva Pharmaceuticals
Endo Pharmaceuticals
Mayne Pharma
Merck & Co. Inc
GSK
Casper Pharma LLC
Bayer
BASF
ADVIL
Pfizer
Johnson & Johnson
Rosemont Pharmaceuticals
Segment by Type
Tablet
Capsule
Segment by Application
Hospital
Clinic
Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Muscle Relaxers report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Muscle relaxers (also called muscle relaxants) are prescription medications that affect muscle function. Healthcare providers prescribe them to treat several symptoms, such as muscle spasms, spasticity and musculoskeletal pain.The term “muscle relaxant” refers to two major drug classes: antispastics and antispasmodics. These two classes differ in their uses, ways of working and side effects.
Global Muscle Relaxers market is projected to reach US$ 5754.8 million in 2029, increasing from US$ 3900 million in 2022, with the CAGR of 5.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Muscle Relaxers market research.
According to a study of Global Burden of Disease (GBD) 2021 data, 1.71 billion individuals globally suffer from musculoskeletal diseases, such as osteoarthritis, rheumatoid arthritis, neck discomfort, low back pain, fractures, and other injuries. People of all ages are afflicted by musculoskeletal problems; however, the prevalence varies by age and diagnosis. With over 149 million years lived with disability (YLDs), or 17% of all YLDs worldwide, musculoskeletal diseases are the main cause of YLDs. The need for muscle relaxants drugs is also being driven by the growing geriatric population, as this group is more vulnerable to illnesses including back pain, muscular tightness, and muscle spasms, especially those connected to injuries to the spine. As a result of this disease muscle relaxants are more in demand, which further drives market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Muscle Relaxers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Novartis
Viatris
Teva Pharmaceuticals
Endo Pharmaceuticals
Mayne Pharma
Merck & Co. Inc
GSK
Casper Pharma LLC
Bayer
BASF
ADVIL
Pfizer
Johnson & Johnson
Rosemont Pharmaceuticals
Segment by Type
Tablet
Capsule
Segment by Application
Hospital
Clinic
Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Muscle Relaxers report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Muscle Relaxers Market Overview
1.1 Product Overview and Scope of Muscle Relaxers
1.2 Muscle Relaxers Segment by Type
1.2.1 Global Muscle Relaxers Market Value Comparison by Type (2023-2029)
1.2.2 Tablet
1.2.3 Capsule
1.3 Muscle Relaxers Segment by Application
1.3.1 Global Muscle Relaxers Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Global Muscle Relaxers Market Size Estimates and Forecasts
1.4.1 Global Muscle Relaxers Revenue 2018-2029
1.4.2 Global Muscle Relaxers Sales 2018-2029
1.4.3 Global Muscle Relaxers Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Muscle Relaxers Market Competition by Manufacturers
2.1 Global Muscle Relaxers Sales Market Share by Manufacturers (2018-2023)
2.2 Global Muscle Relaxers Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Muscle Relaxers Average Price by Manufacturers (2018-2023)
2.4 Global Muscle Relaxers Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Muscle Relaxers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Muscle Relaxers, Product Type & Application
2.7 Muscle Relaxers Market Competitive Situation and Trends
2.7.1 Muscle Relaxers Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Muscle Relaxers Players Market Share by Revenue
2.7.3 Global Muscle Relaxers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Muscle Relaxers Retrospective Market Scenario by Region
3.1 Global Muscle Relaxers Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Muscle Relaxers Global Muscle Relaxers Sales by Region: 2018-2029
3.2.1 Global Muscle Relaxers Sales by Region: 2018-2023
3.2.2 Global Muscle Relaxers Sales by Region: 2024-2029
3.3 Global Muscle Relaxers Global Muscle Relaxers Revenue by Region: 2018-2029
3.3.1 Global Muscle Relaxers Revenue by Region: 2018-2023
3.3.2 Global Muscle Relaxers Revenue by Region: 2024-2029
3.4 North America Muscle Relaxers Market Facts & Figures by Country
3.4.1 North America Muscle Relaxers Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Muscle Relaxers Sales by Country (2018-2029)
3.4.3 North America Muscle Relaxers Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Muscle Relaxers Market Facts & Figures by Country
3.5.1 Europe Muscle Relaxers Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Muscle Relaxers Sales by Country (2018-2029)
3.5.3 Europe Muscle Relaxers Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Muscle Relaxers Market Facts & Figures by Country
3.6.1 Asia Pacific Muscle Relaxers Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Muscle Relaxers Sales by Country (2018-2029)
3.6.3 Asia Pacific Muscle Relaxers Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Muscle Relaxers Market Facts & Figures by Country
3.7.1 Latin America Muscle Relaxers Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Muscle Relaxers Sales by Country (2018-2029)
3.7.3 Latin America Muscle Relaxers Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Muscle Relaxers Market Facts & Figures by Country
3.8.1 Middle East and Africa Muscle Relaxers Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Muscle Relaxers Sales by Country (2018-2029)
3.8.3 Middle East and Africa Muscle Relaxers Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Muscle Relaxers Sales by Type (2018-2029)
4.1.1 Global Muscle Relaxers Sales by Type (2018-2023)
4.1.2 Global Muscle Relaxers Sales by Type (2024-2029)
4.1.3 Global Muscle Relaxers Sales Market Share by Type (2018-2029)
4.2 Global Muscle Relaxers Revenue by Type (2018-2029)
4.2.1 Global Muscle Relaxers Revenue by Type (2018-2023)
4.2.2 Global Muscle Relaxers Revenue by Type (2024-2029)
4.2.3 Global Muscle Relaxers Revenue Market Share by Type (2018-2029)
4.3 Global Muscle Relaxers Price by Type (2018-2029)
5 Segment by Application
5.1 Global Muscle Relaxers Sales by Application (2018-2029)
5.1.1 Global Muscle Relaxers Sales by Application (2018-2023)
5.1.2 Global Muscle Relaxers Sales by Application (2024-2029)
5.1.3 Global Muscle Relaxers Sales Market Share by Application (2018-2029)
5.2 Global Muscle Relaxers Revenue by Application (2018-2029)
5.2.1 Global Muscle Relaxers Revenue by Application (2018-2023)
5.2.2 Global Muscle Relaxers Revenue by Application (2024-2029)
5.2.3 Global Muscle Relaxers Revenue Market Share by Application (2018-2029)
5.3 Global Muscle Relaxers Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Muscle Relaxers Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Novartis Muscle Relaxers Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Viatris
6.2.1 Viatris Corporation Information
6.2.2 Viatris Description and Business Overview
6.2.3 Viatris Muscle Relaxers Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Viatris Muscle Relaxers Product Portfolio
6.2.5 Viatris Recent Developments/Updates
6.3 Teva Pharmaceuticals
6.3.1 Teva Pharmaceuticals Corporation Information
6.3.2 Teva Pharmaceuticals Description and Business Overview
6.3.3 Teva Pharmaceuticals Muscle Relaxers Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Teva Pharmaceuticals Muscle Relaxers Product Portfolio
6.3.5 Teva Pharmaceuticals Recent Developments/Updates
6.4 Endo Pharmaceuticals
6.4.1 Endo Pharmaceuticals Corporation Information
6.4.2 Endo Pharmaceuticals Description and Business Overview
6.4.3 Endo Pharmaceuticals Muscle Relaxers Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Endo Pharmaceuticals Muscle Relaxers Product Portfolio
6.4.5 Endo Pharmaceuticals Recent Developments/Updates
6.5 Mayne Pharma
6.5.1 Mayne Pharma Corporation Information
6.5.2 Mayne Pharma Description and Business Overview
6.5.3 Mayne Pharma Muscle Relaxers Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Mayne Pharma Muscle Relaxers Product Portfolio
6.5.5 Mayne Pharma Recent Developments/Updates
6.6 Merck & Co. Inc
6.6.1 Merck & Co. Inc Corporation Information
6.6.2 Merck & Co. Inc Description and Business Overview
6.6.3 Merck & Co. Inc Muscle Relaxers Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Merck & Co. Inc Muscle Relaxers Product Portfolio
6.6.5 Merck & Co. Inc Recent Developments/Updates
6.7 GSK
6.6.1 GSK Corporation Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Muscle Relaxers Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GSK Muscle Relaxers Product Portfolio
6.7.5 GSK Recent Developments/Updates
6.8 Casper Pharma LLC
6.8.1 Casper Pharma LLC Corporation Information
6.8.2 Casper Pharma LLC Description and Business Overview
6.8.3 Casper Pharma LLC Muscle Relaxers Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Casper Pharma LLC Muscle Relaxers Product Portfolio
6.8.5 Casper Pharma LLC Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Corporation Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Muscle Relaxers Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Bayer Muscle Relaxers Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 BASF
6.10.1 BASF Corporation Information
6.10.2 BASF Description and Business Overview
6.10.3 BASF Muscle Relaxers Sales, Revenue and Gross Margin (2018-2023)
6.10.4 BASF Muscle Relaxers Product Portfolio
6.10.5 BASF Recent Developments/Updates
6.11 ADVIL
6.11.1 ADVIL Corporation Information
6.11.2 ADVIL Muscle Relaxers Description and Business Overview
6.11.3 ADVIL Muscle Relaxers Sales, Revenue and Gross Margin (2018-2023)
6.11.4 ADVIL Muscle Relaxers Product Portfolio
6.11.5 ADVIL Recent Developments/Updates
6.12 Pfizer
6.12.1 Pfizer Corporation Information
6.12.2 Pfizer Muscle Relaxers Description and Business Overview
6.12.3 Pfizer Muscle Relaxers Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Pfizer Muscle Relaxers Product Portfolio
6.12.5 Pfizer Recent Developments/Updates
6.13 Johnson & Johnson
6.13.1 Johnson & Johnson Corporation Information
6.13.2 Johnson & Johnson Muscle Relaxers Description and Business Overview
6.13.3 Johnson & Johnson Muscle Relaxers Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Johnson & Johnson Muscle Relaxers Product Portfolio
6.13.5 Johnson & Johnson Recent Developments/Updates
6.14 Rosemont Pharmaceuticals
6.14.1 Rosemont Pharmaceuticals Corporation Information
6.14.2 Rosemont Pharmaceuticals Muscle Relaxers Description and Business Overview
6.14.3 Rosemont Pharmaceuticals Muscle Relaxers Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Rosemont Pharmaceuticals Muscle Relaxers Product Portfolio
6.14.5 Rosemont Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Muscle Relaxers Industry Chain Analysis
7.2 Muscle Relaxers Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Muscle Relaxers Production Mode & Process
7.4 Muscle Relaxers Sales and Marketing
7.4.1 Muscle Relaxers Sales Channels
7.4.2 Muscle Relaxers Distributors
7.5 Muscle Relaxers Customers
8 Muscle Relaxers Market Dynamics
8.1 Muscle Relaxers Industry Trends
8.2 Muscle Relaxers Market Drivers
8.3 Muscle Relaxers Market Challenges
8.4 Muscle Relaxers Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
